Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Mar 1;177(3):845-50.
doi: 10.1084/jem.177.3.845.

Functional expression of B7/BB1 on activated T lymphocytes

Affiliations

Functional expression of B7/BB1 on activated T lymphocytes

M Azuma et al. J Exp Med. .

Abstract

B7/BB1 is a membrane differentiation antigen expressed on activated B cells, macrophages, and dendritic cells that binds to a counter-receptor, CD28, expressed on T lymphocytes and thymocytes. Interaction between CD28 and B7 results in potent costimulation of T cell activation initiated via the CD3/T cell receptor complex. We now report that B7 is also expressed on activated human peripheral blood T cells, CD4 T cell clones, CD8 T cell clones, and natural killer cell clones. B7 appears relatively late after T cell activation, can be detected on both CD4 and CD8 T cell subsets, and is present on antigen-specific, major histocompatibility complex-restricted CD4 and CD8 T cell clones. Expression of B7 on activated T cells was confirmed by immunoprecipitation from 125I-labeled activated T cells and by detection of B7 transcripts. A B7+ CD4+ T cell clone was able to stimulate a primary allogeneic mixed lymphocyte response using small, resting peripheral blood T cells as responders. The alloantigen-induced proliferative response and cytokine production was partially inhibited by anti-B7 monoclonal antibody. Since activated T cells can coexpress both CD28 and its counter-receptor, B7, this suggests that activated T cells may be capable of autocrine costimulation via the CD28 activation pathway.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1982 Feb;128(2):823-7 - PubMed
    1. Eur J Immunol. 1993 Jan;23(1):295-8 - PubMed
    1. J Exp Med. 1985 Jun 1;161(6):1513-24 - PubMed
    1. Eur J Immunol. 1986 Oct;16(10):1187-93 - PubMed
    1. Hum Immunol. 1986 Dec;17(4):416-25 - PubMed

Publication types

MeSH terms